Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
 |
afrol News - August 14, 2007
S. Makalo
The grants, worth more than US$ 20 million over five years, were suspended in November 2006 due to concerns over the misuse of funds and the ability of the principal recipient and sub-recipients to manage the Global Fund's resources.
The lifting followed arduous efforts and strong commitment by the government, development partners, the country coordinating mechanism and the programs' principal recipient - Le Fonds de Soutien aux Activites en Matiere de Population - which guaranteed that better systems and new clarified responsibilities have been put in place.
It is hoped that this will lead to better oversight and more effective implementation of the two grants. A process to recover the misused funds is said to be under way.
"The Global Fund welcomes the extensive efforts of our partners in Chad to ensure that our concerns have been addressed," said Dr Michel Kazatchkine, Executive Director of the Global Fund.
"We are very pleased that the progress made enables us to support the country again in its fight against the two diseases. Many people in Chad are depending on it."
Since its creation in 2002, the fund has grown to become the dominant financer of programs to fight AIDS, TB and malaria, with almost US $11 billion in firm pledges and approved funding of US$ 7.7 billion for more than 450 programs in 136 countries.
So far, the Global Fund's supported programs have provided AIDS and TB treatment to 1.1 million people and 2.8 million people, respectively and distributed 30 million insecticide-treated bed nets for the prevention of malaria thus averting 1.8 million deaths worldwide.
070814
AO070802
Copyright © 2007 - afrol News. All rights reserved. Reproducing or buying afrol News' articles.
AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .